United States · 
Who invested in Cleveland Diagnostics?
Cleveland Diagnostics's investors include Novo Holdings.
201520172019202120232025
$2.0MVenture$14MVenture
United States · Venture startup
Who invested in Cleveland Diagnostics
Funding summaryUpdated 26 Oct 2026
$16Mraised across 2 rounds since 2015, from 2 sources
$2.0MVenture$14MVenture
- Latest round
- Venture, $14MOct 2025
- Step-upi
- 7.3×
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture, $2.0M Mar 2015
- Biggest round
- $14M Venture · Oct 2025
- Between rounds
- 10.6 years from the last two
The rounds
- Oct 2025
- Mar 2015Venture$2.0M
No investor was named in the report.
From a historical funding recordSEC filing: $2.0M sold, first sale Mar 2015
Founders and team
From Cleveland Diagnostics's own website: 7 on the team.
- Michael IskraChief Executive Officer
- Dara Grantham WrightCEO
- Aimee KestranekChief Operating Officer
- Valerie DixonChief Financial Officer
- Jack KennyChair of the Board
- Madison MedicalPartner
- Sameer RohatgiPartner
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Cleveland Diagnostics
How much has Cleveland Diagnostics raised?
Cleveland Diagnostics has raised $16M across 2 rounds since 2015.
When did Cleveland Diagnostics last raise?
Cleveland Diagnostics's most recent round was a Venture of $14M in Oct 2025.
What was Cleveland Diagnostics's biggest round?
Its most recent round, $14M in Oct 2025, is also its largest on record.
Who backed Cleveland Diagnostics first?
Cleveland Diagnostics's first round on record, in Oct 2025, was backed by Novo Holdings.
What stage is Cleveland Diagnostics at?
Cleveland Diagnostics's latest named round is a Venture, in Oct 2025.
Where is Cleveland Diagnostics based?
Cleveland Diagnostics is based in the United States.
Companies like Cleveland Diagnostics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.